Your comment implies a high level of confidence the zantrene and doxorubicin combo will transfer successfully from lab to clinic,
although the ann mentions many cardio protective agents didn't transfer successfully from animals to the clinic. Considering this why do you have more confidence in the zantrene + dox transferring successfully?
Ann: Breakthrough Zantrene Heart Protection Discovery, page-142
-
- There are more pages in this discussion • 225 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
-0.075(4.12%) |
Mkt cap ! $297.1M | |||
| Open | High | Low | Value | Volume |
| $1.84 | $1.84 | $1.74 | $371.9K | 210.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 488 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.78 | 793 | 1 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |